Filing Details
- Accession Number:
- 0001562180-21-003419
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-11 13:00:00
- Reporting Period:
- 2021-05-10
- Accepted Time:
- 2021-05-11 18:54:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1531048 | Inari Medical Inc. | NARI | Surgical & Medical Instruments & Apparatus (3841) | 452902923 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1644989 | Hill, Mitch C. | C/O Inari Medical, Inc. 9 Parker, Suite 100 Irvine CA 92618 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-10 | 5,000 | $0.46 | 72,937 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-05-10 | 845 | $88.67 | 72,092 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-05-10 | 1,455 | $89.81 | 70,637 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-05-10 | 2,300 | $91.14 | 68,337 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-05-10 | 400 | $92.34 | 67,937 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to buy) | Disposition | 2021-05-10 | 5,000 | $0.00 | 5,000 | $0.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
301,977 | 2029-04-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,600 | Indirect | By Spouse |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020.
- This transaction was executed in multiple trades at prices ranging from $88.31 to $89.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $89.41 to $90.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $90.65 to $91.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $92.16 to $92.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Option vested with respect to 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter.